KING PHARMACEUTICALS (KG) Market Cap (2011 - 2026)
KING PHARMACEUTICALS (KG) market cap from Feb 28, 2011 to Jun 3, 2026. The current KING PHARMACEUTICALS (KG) market cap is $90M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
KING PHARMACEUTICALS (KG) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +6614.36% |
| All Time TTM | +4.25% |
Annual Market Cap change of KING PHARMACEUTICALS (KG)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $90M | +13.10% |
| 2025 | $79M | -96.44% |
| 2011 | $2.23B | N/A |
Comparison KING PHARMACEUTICALS (KG) market cap with competitors
KING PHARMACEUTICALS (KG) market cap is $89.66M.
| Ticker | Name | Market Cap | Upside |
|---|---|---|---|
| EG | Everest Group Ltd | $13.83B | +15321.01% |
| RGA | Reinsurance Group Of America Inc | $13.44B | +14890.18% |
| RNR | RenaissanceRe Holdings Ltd | $12.45B | +13783.75% |
| HG | Hamilton Insurance Group Ltd - Class B | $3.03B | +3284.64% |
| SPNT | SiriusPoint Ltd | $2.61B | +2815.77% |
| GLRE | Greenlight Capital Re Ltd - Class A | $550.07M | +513.49% |
| OXBR | Oxbridge Re Holdings Ltd | $7.67M | -91.45% |